Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials

医学 肾切除术 围手术期 肾功能 肌酐 泌尿科 荟萃分析 输血 外科 内科学
作者
Zhi Wen,Wang Li,Jing Huang,Jing Wang,Caixia Chen,Chongjian Wang,Lin-lin Chen,Xuesong Yang
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:13 被引量:2
标识
DOI:10.3389/fonc.2023.1202587
摘要

Objectives The perioperative, functional, and oncological outcomes of patients with solitary small renal tumors (SRMs) treated with ablation (AT) or partial nephrectomy (PN) remain controversial. The aim of this study was to compare the outcomes of these two surgical techniques. Methods In April 2023, we conducted a literature search in several widely used databases worldwide, including PubMed, Embase, and Google Scholar. Review Manager was used to compare various parameters. The study was registered with PROSPERO (CRD42022377157). Results Our final meta-analysis included 13 cohort studies with a total of 2,107 patients. Compared to partial nephrectomy (PN), ablation (AT) had shorter hospital stays (WMD -2.37 days, 95% CI -3.05 to -1.69; p < 0.00001), shorter operating times (WMD -57.06 min, 95% CI -88.92 to -25.19; p = 0.0004), less postoperative creatinine increases (WMD -0.17 mg/dL, 95% CI -0.29 to -0.05; p = 0.006), less postoperative glomerular filtration rate decreases (WMD -9.84 mL/min/1.73 m2, 95% CI -14.25 to -5.44; p < 0.0001), less postoperative new-onset chronic kidney disease (OR 0.33, 95% CI 0.16 to 0.71; p = 0.005), and less intraoperative blood loss (WMD -285.92 ml, 95% CI -428.44 to -143.40; p < 0.0001). The transfusion rate was lower in the ablation group (OR 0.17, 95% CI 0.06 to 0.51; p = 0.001). The risk of local recurrence was higher in the ablation group (OR 2.96, 95% CI 1.27 to 6.89; p = 0.01), while the risk of distant metastasis was higher in the partial nephrectomy group (OR 2.81, 95% CI 1.28 to 6.18; p = 0.01). The intraoperative and postoperative complication rates were lower in the ablation group (OR 0.23, 95% CI 0.08 to 0.62; p = 0.004 and OR 0.21, 95% CI 0.11 to 0.38; p < 0.00001, respectively). However, overall survival, postoperative dialysis rate, and tumor-specific survival were not different between the two groups. Conclusions Our data suggest that ablation and partial nephrectomy are equally safe and effective in the treatment of small solitary kidney tumors and are better options for patients with poor preoperative physical condition or poor renal function.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
平常的班发布了新的文献求助10
刚刚
Tk完成签到,获得积分20
1秒前
郭翔发布了新的文献求助10
1秒前
YSY完成签到,获得积分10
1秒前
2秒前
daidai发布了新的文献求助10
2秒前
jj关闭了jj文献求助
2秒前
ayra发布了新的文献求助10
2秒前
3秒前
3秒前
Orange应助丁丽采纳,获得10
4秒前
5秒前
滴滴哒完成签到,获得积分10
6秒前
wqd完成签到,获得积分10
6秒前
6秒前
缄默完成签到,获得积分10
7秒前
郭泓嵩完成签到,获得积分10
8秒前
量子星尘发布了新的文献求助10
8秒前
失主修塔完成签到,获得积分10
9秒前
10秒前
颜靖仇发布了新的文献求助10
10秒前
啊汪~完成签到,获得积分10
10秒前
10秒前
无香完成签到,获得积分10
11秒前
Calvin发布了新的文献求助10
11秒前
千空发布了新的文献求助10
12秒前
13秒前
MOON_GDY完成签到,获得积分10
13秒前
传奇3应助六金采纳,获得10
14秒前
jj关闭了jj文献求助
15秒前
15秒前
顾矜应助寂寞的小夏采纳,获得10
16秒前
Calvin完成签到,获得积分10
16秒前
16秒前
wanci应助搬砖民工采纳,获得10
16秒前
17秒前
song完成签到,获得积分10
18秒前
鱼莉完成签到,获得积分10
18秒前
lidd完成签到,获得积分10
18秒前
18秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
Interpretation of Mass Spectra, Fourth Edition 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3951219
求助须知:如何正确求助?哪些是违规求助? 3496615
关于积分的说明 11083276
捐赠科研通 3227034
什么是DOI,文献DOI怎么找? 1784184
邀请新用户注册赠送积分活动 868252
科研通“疑难数据库(出版商)”最低求助积分说明 801091